SE9901884D0 - Novel compounds their use and preparation - Google Patents
Novel compounds their use and preparationInfo
- Publication number
- SE9901884D0 SE9901884D0 SE9901884A SE9901884A SE9901884D0 SE 9901884 D0 SE9901884 D0 SE 9901884D0 SE 9901884 A SE9901884 A SE 9901884A SE 9901884 A SE9901884 A SE 9901884A SE 9901884 D0 SE9901884 D0 SE 9901884D0
- Authority
- SE
- Sweden
- Prior art keywords
- ring
- saturated
- disorders
- substituted
- ring members
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/18—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/20—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
THE INVENTION RELATES TO COMPOUNDS OF THE GENERAL FORMULA(I) : WHEREIN AR IS OPTIONALLY SUBSTITUTED ARYL OR HETEROARYL ;A IS (I) -O-, -S-, -SO2-, -NH-, (II) A C1-4-ALKYL- OR C1-6-ACYL-SUBSTITUTED NITROGEN ATOM OR (III) A C1-8-ALKYLENE CHAIN OR A HETEROALKYLENE CHAIN HAVING 2 TO 8 CHAIN ATOMS, WHICH OPTIONALLY CONTAINS AT LEAST ONE UNSATURATION, AND WHICH MAY BE SUBSTITUTED AND/OR CONTAIN A BRIDGE TO FORM A SATURATED OR PARTIALLY OR FULLY UNSATURATED RING HAVING 3-8 RING MEMBERS ;B IS -C(R4)(R5)-, -OC(R4)(R5)-, -N(R6)C(R4)(R5)-, -N(R6)-, -O-, -S- OR -SO2- ;R IS OPTIONALLY SUBSTITUTED C3-8-CYCLOALKYL, ARYL OR HETEROARYL ;R1 IS (I) A SATURATED OR UNSATURATED AZACYCLIC OR AMINOAZACYCLIC RING, OR A SATURATED DIAZACYCLIC OR AMINODIAZACYCLIC RING, WHICH HAS 4 TO 7 RING MEMBERS, OR A SATURATED AMINOAZABICYCLIC, AZABICYCLIC OR DIAZABICYCLIC RING WHICH HAS 7 TO 10 RING MEMBERS, WHICH RINGS OPTINALLY ARE SUBSTITUTED IN ONE OR MORE POSITIONS, OR A GROUP -[C(R4)(R5)]xN(R2)(R3)] ; R2, R3, R4, R5, R6 AND x ARE AS DEFINED IN THE CLAIMS, AND N IS 0 OR 1 ;AND PHARMACEUTICALLY ACCEPTABLE SALTS, HYDRATES AND PRODRUG FORMS THEREOF. THE COMPOUNDS MAY BE PREPARED BY PER SE CONVENTIONAL METHODS AND CAN BE USED FOR TREATINGA HUMAN OR ANIMAL SUBJECT SUFFERING FROM A SEROTONIN-RELATED DISORDER, SUCH AS EATING DISORDERS, ESPECIALLY OBESITY, MEMORY DISORDERS, SCHIZOPHRENIA, MOOD DISORDERS, ANXIETY DISORDERS, PAIN, SEXUAL DYSFUNCTIONS, AND URINARY DISORDERS. THE INVENTION ALSO RELATES TO SUCH USE AS WELL AS TO PHARMACEUTICAL COMPOSITIONS COMPRISING A COMPOUND OF FORMULA (I).
Priority Applications (27)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9901884A SE9901884D0 (en) | 1999-05-21 | 1999-05-21 | Novel compounds their use and preparation |
DK00931877T DK1178973T3 (en) | 1999-05-21 | 2000-05-19 | Pyrazinyl-piperazine compounds, their use and preparation |
AT00931877T ATE313535T1 (en) | 1999-05-21 | 2000-05-19 | PYRAZINYL-PIPERAZINE COMPOUNDS, THEIR APPLICATION AND PRODUCTION |
MXPA01011905A MXPA01011905A (en) | 1999-05-21 | 2000-05-19 | Novel compounds, their use and preparation. |
PCT/SE2000/001017 WO2000076984A2 (en) | 1999-05-21 | 2000-05-19 | Novel compounds, their use and preparation |
DE60024986T DE60024986T2 (en) | 1999-05-21 | 2000-05-19 | PYRAZINYL-PIPERAZINE COMPOUNDS, THEIR USE AND MANUFACTURE |
CNB008102449A CN1242995C (en) | 1999-05-21 | 2000-05-19 | Novel compounds, their use and preparation |
CA002374898A CA2374898C (en) | 1999-05-21 | 2000-05-19 | Pyrazinyl-piperazine compounds, their use and preparation |
ES00931877T ES2252004T3 (en) | 1999-05-21 | 2000-05-19 | NEW COMPOUNDS, ITS USE AND PREPARATION. |
KR1020017014888A KR100722090B1 (en) | 1999-05-21 | 2000-05-19 | Novel compounds, their use and preparation |
ARP000102461A AR030022A1 (en) | 1999-05-21 | 2000-05-19 | NEW COMPOUNDS, PHARMACEUTICAL COMPOSITIONS OF THE SAME, TREATMENT METHOD, USE AND PREPARATION OF THEM |
BR0010783-2A BR0010783A (en) | 1999-05-21 | 2000-05-19 | New compounds, their use and preparation |
NZ515786A NZ515786A (en) | 1999-05-21 | 2000-05-19 | Aryl compounds, their preparation and use in the preparation of medicaments for the treatment of serotonin-related disorders |
EA200101223A EA005820B1 (en) | 1999-05-21 | 2000-05-19 | Agonists and antagonists of 5-ht2c receptors |
EP00931877A EP1178973B1 (en) | 1999-05-21 | 2000-05-19 | Pyrazinyl-piperazine- compounds, their use and preparation |
JP2001503842A JP4831903B2 (en) | 1999-05-21 | 2000-05-19 | Novel compounds, their use and production |
MYPI20002186A MY135666A (en) | 1999-05-21 | 2000-05-19 | Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases |
PE2000000479A PE20010125A1 (en) | 1999-05-21 | 2000-05-19 | PIPERAZINYL-PIRAZINE DERIVATIVE COMPOUNDS THAT BIND TO THE 5-HT 2C RECEPTOR |
AU49690/00A AU777276C (en) | 1999-05-21 | 2000-05-19 | Novel compounds, their use and preparation |
IL14658200A IL146582A0 (en) | 1999-05-21 | 2000-05-19 | Novel compounds, their use and preparation |
US09/589,282 US6465467B1 (en) | 1999-05-21 | 2000-06-08 | Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases |
IL146582A IL146582A (en) | 1999-05-21 | 2001-11-19 | Compound for treating a serotonin-related disease, particularly 5-ht2 receptor-related |
ZA200109571A ZA200109571B (en) | 1999-05-21 | 2001-11-20 | Novel compounds, their use and preparation. |
NO20015686A NO322220B1 (en) | 1999-05-21 | 2001-11-21 | New compounds, their use and manufacture |
US10/269,670 US7534794B2 (en) | 1999-05-21 | 2002-10-11 | Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases |
HK03100371.6A HK1048311B (en) | 1999-05-21 | 2003-01-15 | Compounds, their use and preparation |
US10/873,852 US7071180B2 (en) | 1999-05-21 | 2004-06-22 | Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9901884A SE9901884D0 (en) | 1999-05-21 | 1999-05-21 | Novel compounds their use and preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9901884D0 true SE9901884D0 (en) | 1999-05-21 |
Family
ID=20415714
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9901884A SE9901884D0 (en) | 1999-05-21 | 1999-05-21 | Novel compounds their use and preparation |
Country Status (6)
Country | Link |
---|---|
JP (1) | JP4831903B2 (en) |
AR (1) | AR030022A1 (en) |
MY (1) | MY135666A (en) |
PE (1) | PE20010125A1 (en) |
SE (1) | SE9901884D0 (en) |
ZA (1) | ZA200109571B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1608373A4 (en) * | 2003-03-19 | 2010-09-29 | Exelixis Inc | Tie-2 modulators and methods of use |
CL2004000826A1 (en) * | 2003-04-25 | 2005-03-04 | Pfizer | USE OF AN AGONIST FOR THE 5-HT2C RECEPTOR TO PREPARE A USEFUL MEDICINAL PRODUCT IN THE TREATMENT OF URINARY INCONTINENCE CAUSED BY STRESS, WITH THE CONDITION THAT THE AGONIST IS NOT 1- [6-CHLORINE-5- (TRIFLUOROMETIL) -2- PIRIDINIL] PIPERAZINA (ORG-129 |
EP2418191A1 (en) | 2005-02-28 | 2012-02-15 | Meiji Co., Ltd. | Long-chain trimethoxyphenylalkanol derivatives, and pharmaceuticals comprising the same |
BRPI0615248A2 (en) * | 2005-08-26 | 2009-07-14 | Shionogi & Co | derivative having ppar agonist activity |
JP6635999B2 (en) * | 2017-10-13 | 2020-01-29 | 株式会社ダイセル | Method for producing potassium salt, and potassium salt |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI193974A (en) * | 1973-07-13 | 1975-01-14 | Merck & Co Inc | |
GB9420999D0 (en) * | 1994-10-18 | 1994-12-07 | Smithkline Beecham Plc | Novel compounds |
-
1999
- 1999-05-21 SE SE9901884A patent/SE9901884D0/en unknown
-
2000
- 2000-05-19 JP JP2001503842A patent/JP4831903B2/en not_active Expired - Fee Related
- 2000-05-19 AR ARP000102461A patent/AR030022A1/en active IP Right Grant
- 2000-05-19 MY MYPI20002186A patent/MY135666A/en unknown
- 2000-05-19 PE PE2000000479A patent/PE20010125A1/en not_active Application Discontinuation
-
2001
- 2001-11-20 ZA ZA200109571A patent/ZA200109571B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200109571B (en) | 2002-11-20 |
JP2003502317A (en) | 2003-01-21 |
AR030022A1 (en) | 2003-08-13 |
MY135666A (en) | 2008-06-30 |
PE20010125A1 (en) | 2001-02-06 |
JP4831903B2 (en) | 2011-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200101223A1 (en) | NEW CONNECTIONS, THEIR APPLICATION AND RECEIVING | |
AP1860A (en) | Aryl fused azapolycyclic compounds. | |
EA200500342A1 (en) | HETEROCYCLIC SUBSTITUTED PIPERASINES FOR THE TREATMENT OF SCHIZOPHRENIA | |
FI905839A (en) | A process for the preparation of new therapeutically useful tricyclic nitrogen-containing compounds | |
WO2005092858A3 (en) | Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonist | |
SE0104332D0 (en) | Therapeutic agents | |
GEP20104959B (en) | Bicyclic [3.1.0] derivatives as glycine transporter inhibitors | |
RS20050182A (en) | Derivatives of dioxane-2-alkyl carbamates,preparation method thereof and application of same in therapeutics | |
MY133445A (en) | 2-arylethyl-(piperidin-4-ylmethyl)amine derivetives | |
ATE66913T1 (en) | AMIDE COMPOUNDS, PROCESS FOR THEIR PRODUCTION AND COMPOSITION FOR ACTIVATING GASTROMOTOR FUNCTIONS. | |
BG104983A (en) | Aryl fused azapolycyclic compounds | |
SE9901884D0 (en) | Novel compounds their use and preparation | |
CO4920251A1 (en) | HEXAHYDRO COMPOUNDS 1 H. -PIRROLIZINA 7 A. -HETEROCICLICO- SUBSTITUTED USEFUL IN THE CONTROL OF CHEMICAL SYNAPTIC TRANSMISSION | |
DE69618050T2 (en) | Substituted benzylthienylpiperazines, their use as medicines and processes for their manufacture | |
DE60110233D1 (en) | NEW N- (2-PHENYL-3-AMINOPROPYL) NAPHTAMIDE | |
MXPA06000892A (en) | Aryl fused azapolycyclic compounds. | |
EP1057829A4 (en) | Novel compounds and pharmaceutical compositions containing the same |